NCT00481637View on ClinicalTrials.gov

Study to Evaluate Immune Responses in Neurologically Normal Cancer Patients

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Cancer
Trial Locations (1)

10021

Rockefeller University Hospital, New York

All Listed Sponsors
lead

Rockefeller University

OTHER

NCT00481637 - Study to Evaluate Immune Responses in Neurologically Normal Cancer Patients | Biotech Hunter | Biotech Hunter